In vitro and in vivo evaluation of a novel mitomycin nanomicelle delivery system. Issue 26 (13th May 2019)

• Record Type: Journal Article
• Authors: Yang, Hongmei; Wang, Miao; Huang, Yihe; Qiao, Qiaoyu; Zhao, Chunjie; Zhao, Min
• Is Part Of: RSC advances. Volume 9:Issue 26(2019)
• Page Start: 14708
• Page End: 14717
• Publication Date: 2019-05-13
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c9ra02660f
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : The introduction of a micellar delivery system of MMC increase efficiency, reduce toxicity and enhance specific interactions in tumor. Abstract : Mitomycin C (MMC), naturally synthesized by Streptomyces caespitosus, is a potent antineoplastic antibiotic for the treatment of various solid tumors. However, the defects of conventional MMC injections have greatly limited its clinical application due to its toxic side effects and non-specific interactions. To solve this problem, the PEG2k -Fmoc-Ibuprofen (PEG-FIbu) micellar nanocarrier was synthesized and the MMC-loaded micelles (PEG-FIbu/MMC) were prepared by thin film hydration method and characterized. Ibuprofen was used as a hydrophobic domain of PEG-FIbu nanocarrier, and we expect it to synergize with codelivered MMC in the overall antitumor activity. The in vitro release of PEG-FIbu/MMC was examined by dialysis method using MMC injection as a control. Our data suggested that PEG-FIbu/MMC micelles presented appropriate particle size, low CMC value, good stability, high drug loading efficiency and sustained release properties. In vitro cytotoxicity studies with several tumor cell lines showed that the carrier was effective in mediating intracellular delivery of MMC to tumor cells. In vivo pharmacokinetics, tissue distribution and therapeutic study proved that PEG-FIbu/MMC micelles prolonged blood circulation, significantly improved the tumor accumulation and therapeutic efficacy, and reduced undesirable side effect on normal tissues compared to MMC injection. In general, PEG-FIbu/MMC micelles represented an effective strategy to improve the performance for the delivery of MMC and safety of medication.